Location History:
- Princeton, NJ (US) (2010)
- Kranzberg, DE (2013 - 2018)
Company Filing History:
Years Active: 2010-2018
Title: **Franz Aberl: Innovator in Fluid Sample Analysis**
Introduction
Franz Aberl is an accomplished inventor based in Kranzberg, Germany, known for his significant contributions to the field of fluid sample analysis. With a total of five patents to his name, Aberl has focused on developing innovative methods and devices that enhance the detection of analytes in various fluids, especially concerning health diagnostics.
Latest Patents
Among his latest patents, one notable invention is a **Device for the detection of an analyte in a fluid sample**. This innovation introduces a method aimed at identifying pathogens in human body fluids using a swab for sample collection. Another significant patent is a **Method to increase specificity and/or accuracy of lateral flow immunoassays**. This invention outlines novel methods and devices designed to prevent interfering substances from skewing the results of lateral flow immunoassays. Key features of this patent include a test strip with a capturing zone using mobile capturing reagents to isolate interfering substances from the analyte, thereby improving the accuracy of the test results.
Career Highlights
Throughout his career, Franz Aberl has been associated with prominent companies such as Rapid Pathogen Screening, Inc. and Quidel Corporation. These roles have allowed him to leverage his expertise to develop groundbreaking diagnostics solutions that have made a meaningful impact in the healthcare sector.
Collaborations
Franz has collaborated with notable professionals in his field, including Marcus Scheibenzuber and Robert W. VanDine. These partnerships have fostered a creative environment that has propelled innovation in fluid analysis technology.
Conclusion
Franz Aberl continues to push the envelope in the realm of healthcare diagnostics through his inventions and collaborations. His patented technologies stand as a testament to his commitment to enhancing the accuracy and reliability of medical testing, thereby supporting better healthcare outcomes.